Results 61 to 70 of about 24,171 (197)

Adenoid Cystic Carcinoma of Trachea [PDF]

open access: yesIndian Journal of Surgery, 2016
Adenoid cystic carcinoma (ACC) is the second most common primary malignant tumor of the trachea, after squamous cell carcinoma. Patients present with upper airway obstructive symptoms and signs including dyspnoea, cough, haemoptysis, and stridor which are often insidious, delaying diagnosis and optimal management.
Ashish, Varghese   +2 more
openaire   +2 more sources

Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors [PDF]

open access: yes, 2011
Objectives: The present study was undertaken to assess and compare the immunohistochemical expression of Bcl-2 in selected benign and malignant salivary gland tumors. Study Design: A total of 50 cases of buffered formalin-fixed, paraffin embedded tissues
Kumar, G.S.   +2 more
core   +1 more source

Primary Esophageal Adenoid Cystic Carcinoma [PDF]

open access: yesGut and Liver, 2007
Adenoid cystic carcinoma (ACC) is common in the salivary glands but rare in the esophagus. Routine esophagogastroscopy performed in a 54-year-old woman as part of a medical check-up revealed a submucosal tumor (1.5x1.0 cm) at the mid-esophagus. Endoscopic ultrasonography revealed a lesion with mixed echogenicity in the submucosal layer.
Youn Ju, Na   +11 more
openaire   +3 more sources

Adenoid cystic carcinoma of the peripheral lung: a case report

open access: yesWorld Journal of Surgical Oncology, 2010
Adenoid cystic carcinoma of the peripheral lung is a rare entity. We recently encountered a patient with adenoid cystic carcinoma. A 75-year-old woman showed a nodular lesion with 10 mm in diameter in the right upper lung field on chest radiography.
Kitada Masahiro   +6 more
doaj   +1 more source

Malignant salivary gland tumours: Can fast neutron therapy results point the way to carbon ion therapy? [PDF]

open access: yes, 2013
BACKGROUND AND PURPOSE: To evaluate the outcome of malignant salivary gland tumours treated with neutron therapy to assess the potential for other high linear energy transfer (LET) beams.
Carrara, Henri   +6 more
core   +1 more source

TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. [PDF]

open access: yes, 2006
The putative role of TP53 and p16INK4A tumor suppressor genes and Ras oncogenes in the development and progression of salivary gland neoplasias was studied in 28 cases of pleomorphic adenomas (PA), 4 cases of cystic adenocarcinomas, and 1 case of ...
AGNESE, Valentina   +18 more
core   +1 more source

A report of laryngeal adenocystic carcinoma metastatic to the spleen and the role of splenectomy in the management of metastatic disease: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Adenoid cystic carcinoma (ACC) of the larynx is a rare malignancy characterized by an indolent course and late pulmonary metastases. Metastases from the larynx to the spleen are an unusual event.
Murray Bryce W   +3 more
doaj   +1 more source

Review of salivary gland neoplasms [PDF]

open access: yes, 2012
Salivary gland tumours most often present as painless enlarging masses.Most are located in the parotid glands andmost are benign. The principal hurdle in their management lies in the difficulty in distinguishing benign from malignant tumours ...
Chan, JYW, To, VSH, Tsang, RKY, Wei, WI
core   +1 more source

Cytologic Characteristics of Adenoid Cystic Carcinoma of the Cervix Uteri – Case Report [PDF]

open access: yes, 2010
Adenoid cystic carcinoma is a rare malignancy, usually found in the salivary glands, although this unusual tumor can be found at other sites of the body.
Ana Barišić   +6 more
core   +1 more source

Lesions mimicking lacrimal gland pleomorphic adenoma [PDF]

open access: yes, 2010
Aim: To report a series of patients with lacrimal gland lesions simulating the clinicoradiological features of lacrimal gland pleomorphic adenoma (LGPA). Methods: Multicentre retrospective, interventional case series.
Cannon, P.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy